Overall, the loss of DR4 sufficiently protected tumor cells from undergoing apoptosis enhancement by TRAIL in cooperation with CD13 inhibition, thus demonstrating a key role of DR4 elevation in augmenting TRAIL-induced cell death in the presence of CD13 inhibition. This evidence concerns the gene TNFRSF10A and neoplasm.